The FDA’s policies often harm ordinary citizens by limiting access to affordable medications and safer alternatives. Medicaid patients, for example, are frequently denied access to certain treatments because the FDA has not approved them for specific uses, despite strong scientific support for their efficacy. Additionally, the agency’s resistance to allowing the importation of life-saving medications contributes to financial hardship and medical bankruptcies​.